A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00113412
Recruitment Status : Unknown
Verified March 2006 by Samaritan Pharmaceuticals, Inc.
Recruitment status was:  Active, not recruiting
First Posted : June 8, 2005
Last Update Posted : March 22, 2006
Information provided by:
Samaritan Pharmaceuticals, Inc